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Abstract
Background and Purpose—There are limited data about the reliability of subtype 
classification in childhood arterial ischemic stroke, an issue that prompted the IPSS (International 
Pediatric Stroke Study) to develop the CASCADE criteria (Childhood AIS Standardized 
Classification and Diagnostic Evaluation). Our purpose was to determine the CASCADE criteria’s 
reliability in a population of children with stroke.
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Methods—Eight raters from the IPSS reviewed neuroimaging and clinical records of 64 cases 
(16 cases each) randomly selected from a prospectively collected cohort of 113 children with 
arterial ischemic stroke and classified them using the CASCADE criteria. Clinical data abstracted 
included history of present illness, risk factors, and acute imaging. Agreement among raters was 
measured by unweighted κ statistic.
Results—The CASCADE criteria demonstrated a moderate inter-rater reliability, with an overall 
κ statistic of 0.53 (95% confidence interval [CI]=0.39–0.67). Cardioembolic and bilateral cerebral 
arteriopathy subtypes had much higher agreement (κ=0.84; 95% CI=0.70–0.99; and κ=0.90; 95% 
CI=0.71–1.00, respectively) than cases of aortic/cervical arteriopathy (κ=0.36; 95% CI=0.01–
0.71), unilateral focal cerebral arteriopathy of childhood (FCA; κ=0.49; 95% CI=0.23–0.76), and 
small vessel arteriopathy of childhood (κ=−0.012; 95% CI=−0.04 to 0.01).
Conclusions—The CASCADE criteria have moderate reliability when used by trained and 
experienced raters, which suggests that it can be used for classification in multicenter pediatric 
stroke studies. However, the moderate reliability of the arteriopathic subtypes suggests that further 
refinement is needed for defining subtypes. Such revisions may reduce the variability in the 
literature describing risk factors, recurrence, and outcomes associated with childhood arteriopathy.
Keywords
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Childhood arterial ischemic stroke (AIS) has received increasing attention as a cause of 
morbidity and mortality in the pediatric population. Several population-based studies in the 
United States demonstrate an incidence of childhood AIS at 2 cases per 100 000 children per 
year,1 with an incidence in other studies from Asia and Europe ranging from 0.2 to 7.9 per 
100 000 children per year.2 Of the estimated children in the United States,3 >1000 will suffer 
an AIS this year. The pathogenesis, risk factors, recurrence rates, outcomes, and optimal 
treatment strategies for childhood AIS have only recently been explored. International 
networks, such as the IPSS (International Pediatric Stroke Study), have initiated large 
multicenter cohort studies demonstrating the basic natural history of this disease.4 Even with 
these early studies, much remains unknown about childhood AIS.
One of the greatest barriers to childhood AIS research has been the lack of a validated and 
reliable classification system.5 As in adult stroke,6–8 multicenter efforts to determine cause, 
risk factors, treatment, and outcomes in childhood AIS will depend on a reliable and 
validated classification system. Adult classification systems are not applicable to children, in 
whom AIS causes are vastly different. Previous efforts to create classification systems have 
not been widely adopted,9,10 leading the IPSS to create a consensus-based classification 
system, the CASCADE criteria (Childhood AIS Standardized Classification and Diagnostic 
Evaluation).11 Briefly, the primary CASCADE classification is based on anatomic site of 
disease including the heart, the great vessels of the neck, or the intracranial vessels (Table 1). 
Secondary subtypes include additional information like genetic causes of arteriopathy, 
hemoglobinopathy, or infections (Table 1). Acute classification is based on clinical history 
and imaging within the first month after the incident stroke, and the chronic classification 
allows incorporation of findings after 1 month.
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Although the initially reported κ statistic for inter-rater reliability of the CASCADE system 
was encouraging (κ=0.61–0.78), it was based on a limited number of raters in an unpowered 
analysis of 7 cases.11 In addition, the reliability of each individual primary subcategory and 
the secondary criteria were not tested. The objective of this study was to describe the 
reliability of the CASCADE criteria using a large number of prospectively collected cases 
using raters trained in a standardized format. In addition, data were analyzed to preliminarily 
test the CASCADE criteria’s secondary subtypes.
Methods
Cases were randomly selected for the current cross-sectional study from an existing 
multicenter cohort of 113 prospectively enrolled children with AIS with IRB approval at 
each participating center. This prospectively collected cohort of childhood AIS cases was 
originally designed to test the reliability of the Pediatric National Institutes of Health Stroke 
Scale (PedNIHSS).12
Eight raters from high-enrolling IPSS centers were randomly paired, and each of the 4 pairs 
was randomly assigned 16 cases to review (Figure) and compared with each other. With a 
sample size of 64, an a priori power analysis predicted that if results reveal a κ of 0.75, it 
could be concluded with 95% confidence that the true value of κ is between 0.70 and 0.80. 
Cases previously known to the raters were excluded from randomization. Deidentified case 
files were created for each case and included the acute magnetic resonance imaging on 
Compact Disc Read-Only Memory (CD-ROM), the radiology report of the magnetic 
resonance imaging, the initial history of present illness from the attending neurologist at the 
time of stroke, and the 3-month follow-up note from the neurology clinic (when available). 
The PedNIHSS study’s case report form also included information about demographics, 
family history, medical evaluation, and treatment for each case. In addition, acute vascular 
imaging (at least one of the following: computed tomography angiography [CTA], magnetic 
resonance angiography, or conventional angiogram) was included for all 64 cases. When 
available, chronic imaging (>30 days) was included in case files as well (6/64).
To reduce potential bias, case files were systematically redacted by trained personnel (R.B. 
and A.H.) and then rechecked by a pediatric stroke neurologist (J.A.-W.) before 
dissemination. Eliminated data included (1) any notation of working diagnosis or 
classification of stroke subtype, (2) all assessments and plans, and (3) any official diagnosis 
on radiographic reports.
Each case was rated by 2 randomly paired experts in childhood stroke (7 neurologists and 1 
hematologist: N.A.G., W.L., M.M.D., H.J.F., C.A.L., L.C.J., A.K., and L.A.B.). All 8 raters 
were provided a manual detailing the study procedures and the CASCADE rating system. 
Each rater also participated in a standardized 30-minute phone and Power Point training 
session on the implementation of the CASCADE criteria. Each rater was permitted to use 
local expertise at his or her center; specifically, the examiner could consult with an 
institutional pediatric neuroradiologist or cardiologist to assist in the classification of 
cerebrovascular and cardiac findings, respectively (as would be performed in actual clinical 
settings).
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Initial review included only acute information available at presentation and within 30 days 
after stroke onset and was termed the acute classification. The raters then classified each 
case using: (1) the primary CASCADE criteria basic 7 subtypes, (2) the primary CASCADE 
criteria expanded 19 subtypes, (3) the CASCADE criteria secondary subtypes, and (4) their 
current (ad hoc) classification system (Table 1).11 A second review—termed the chronic 
classification—was then undertaken with all data beyond 30 days post stroke (n=62/64) 
available. The raters then reclassified each case using: (1) the primary CASCADE criteria 
basic 7 subtypes, (2) the primary CASCADE criteria expanded 19 subtypes, (3) the 
CASCADE criteria secondary subtypes, and (4) their current (ad hoc) classification system 
(Table 1). Raters were also asked to rate the usability of the system and their confidence in 
their classification throughout their case review.
Inter-rater reliability for the CASCADE criteria was then evaluated by chance-adjusted 
agreement by calculating a κ statistic, along with 95% confidence intervals (95% CI) using 
the (Wald/other) method. An overall κ was determined for the cases in the acute and chronic 
setting for the primary 7 subtypes, primary expanded 19 subtypes, and secondary subtypes. 
As proposed by Landis and Koch,13 we used the following interpretations of κ values: >0.8, 
near-perfect agreement; 0.61 to 0.80, substantial agreement; 0.41 to 0.60, moderate 
agreement; 0.21 to 0.40, fair agreement; and <0.20, slight agreement.
Results
Raters obtained an overall agreement in 40 out of 64 cases using the basic 7-subtype 
CASCADE criteria with a κ of 0.53 (95% CI=0.39–0.67), demonstrating a moderate 
agreement (Table 2) that was similar among the 4 pairs. When using the expanded 19-
subtype criteria, inter-rater reliability demonstrated fair agreement, with a κ of 0.39 (95% 
CI=0.25–0.52). Follow-up rating for chronic classification using the basic 7-subtype system 
was also moderate (κ=0.49; 95% CI=0.35–0.64) for the 62 cases with data beyond 30 days 
and was similar to agreement in the acute classification (P=0.97). Inter-rater agreement, as 
measured by unweighted κ, varied greatly among each of the basic 7 subcategories in the 
acute setting (Table 3). Acutely, near-perfect agreement occurred in cases of cardioembolic 
stroke (n=32/36; κ=0.84; 95% CI=0.70–0.99) and bilateral cerebral arteriopathy of 
childhood (n=10/11; κ=0.90; 95% CI=0.71–1.00). Moderate agreement was attained in 
cases of unilateral FCA (n=14/25; κ=0.49; 95% CI=0.23–0.76), whereas fair agreement was 
observed in aortic/cervical arteriopathy (8/15; κ=0.36; 95% CI=0.01–0.7) and the other 
subcategory (n=16/33; κ=0.33; 95% CI=0.09–0.56). Small vessel arteriopathy of childhood 
(n=0/2; κ=−0.02; 95% CI=−0.04 to 0.01) and multifactorial disease (n=0/6; κ=−0.04; 95% 
CI=−0.09 to 0.00) had no agreement.
Raters reported that they were confident or very confident in their acute primary 
classification in 70 out of 128 cases when using the CASCADE criteria, while reporting a 
similar confidence when using their own system (71/128). Chronic classification had similar 
distributions. Although all 64 cases had magnetic resonance angiography imaging available 
of the head, 5 cases had additional CTA imaging provided by their center. In cases with 
additional CTA imaging, there was agreement in 4 out of 5 cases classified as FCA (1), 
cardioembolic (1), and other (2). When asked about imaging, raters reported that imaging 
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quality had little, very little, or no impact on their ability to rate the vignettes in 110 out of 
128 (86%) of cases. In 14 cases (11%), the raters reported that the quality of the image 
impaired the ability of the raters to classify “somewhat” and in 4 cases “very much” or “a 
great deal.”
In the secondary classification, the inter-rater reliability was measured independently for 
each category, as these selections are not mutually exclusive (Table 4). Acutely, the genetic 
vasculopathy subtype demonstrated substantial agreement (κ=0.78; 95% CI=0.56–1.00), 
whereas the inflammatory subcategory had moderate agreement (κ=0.55; 95% CI=0.09–
1.00). Toxin, hematologic, and infectious subcategories all had slight to fair agreement.
Discussion
In 2012, the child CASCADE criteria was established as a consensus-based classification in 
childhood AIS via a modified Delphi method by 12 pediatric stroke experts.11 This is the 
first powered reliability analysis of the primary 7-subtype criteria, using 64 prospectively 
collected cases. In addition, this is the first study examining the inter-rater reliability of the 
expanded 19-subtye CASCADE criteria and the secondary CASCADE criteria. A previous 
report, using a small number of cases (7) and the 7-subtype CASCADE criteria, had 
demonstrated a κ statistic of 0.61 to 0.78, suggesting substantial agreement among raters.11 
The current powered analysis suggests that the CASCADE is a useful tool for classification 
of childhood AIS. The primary 7-subtype criteria demonstrate moderate inter-rater 
agreement, with a κ of 0.53, and a CI spanning moderate to substantial agreement. This κ 
statistic compares favorably with the initial inter-rater reliability of the first adult stroke 
classification (the Trial of Org 10172 in Acute Stroke Treatment criteria), which had a κ of 
0.54 when originally evaluated by trained raters.14,15 When using the expanded 19-subtype 
criteria, agreement in the CASCADE criteria decreases into the fair category, with a κ of 
0.39. The fair agreement within the 19-subtype criteria suggests that in future applications of 
the CASCADE criteria—with adjustments from these data—the 19-subtype system may 
provide a more granular, yet reliable system for classification. The first-ever testing of the 
secondary classification suggests that the genetic and inflammatory categories have adequate 
definitions for use with moderate to substantial reliability, whereas the infectious and 
hematologic categories need further refinement.
Most interestingly, inter-rater reliability within subcategories varied greatly with near-perfect 
agreement in the cardioembolic and bilateral cerebral arteriopathy categories and only fair to 
moderate agreement in the aortic/cervical arteriopathy and FCA categories. Although the 
raters for this study are all experienced pediatric stroke specialists and had participated in 
formal training sessions, a lack of substantial agreement in the aortic/cervical arteriopathy 
and FCA categories remained, highlighting the difficulty in categorizing stenotic focal 
arteriopathies in children. These findings suggest that even specialists in this area, who are 
guided by standardized definitions, have different interpretations of the clinical and 
radiographic data in children with stroke and arteriopathic abnormalities.
Furthermore, the lack of substantial agreement in these categories may explain some of the 
variable reports about arteriopathy subtypes in the literature. As an example, reported 
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recurrence risk of childhood stroke because of arteriopathy is highly variable, with a cohort 
of 50 children from the United Kingdom with stroke and intracranial arteriopathy only 
having 5 recurrent events (10%) at a median interval follow-up of 38 months,16 whereas a 
US cohort of 22 children with stroke and arteriopathy had a recurrence risk of 66% at 5 
years.17 Although methods and treatment strategies likely differed in these cohorts, the large 
discrepancy between their findings suggests that a lack of standardized definitions may play 
a role in these vastly different conclusions. The majority of disagreement in the current study 
came from cases that were identified as arteriopathy by one rater and other by another rater, 
emphasizing the uncertainty of this category. Indeed, our results suggest that even when 
using standardized definitions from the CASCADE criteria, inter-rater reliability of aortic/
cervical arteriopathy and FCA are only fair to moderate.
The inter-rater reliability of small vessel arteriopathy in the CASCADE criteria is the most 
unreliable of any subtype within the study, although this conclusion is limited by small 
numbers in this category. This result may also be influenced by a wide spectrum of 
preexisting definitions of vasculitis used among the raters. Indeed, previous reports in the 
literature suggest a vastly different incidence of vasculitis in childhood stroke, depending on 
study location. Although an international multicenter cohort of 525 patients identified only 
6% (33/525) of their subjects as having vasculitis, a single Canadian cohort identified 24 
patients with small vessel primary central nervous system vasculitis at a single tertiary care 
center from 2002 to 2009.18 These findings are likely the result of variable definitions for 
vasculitis in the pediatric stroke field, as well as variability in work-up including lumbar 
puncture and brain biopsy.
This study has several limitations. The primary limitation is the small number of cases 
identified with small vessel arteriopathy and several of the secondary subtypes. Given the 
small numbers in these subcategories, generalization about the reliability of classification is 
difficult. A second limitation was the lack of a standardized evaluation for children with 
acute stroke. Although this is likely a real-world scenario, variability of work-up, especially 
vascular imaging, may have led to challenges in classification. In addition, the quality of 
vascular imaging may have played a role in misclassification, as raters considered poor 
imaging quality as somewhat to greatly influential in 14% of cases they rated. Interestingly, 
when raters were provided CTA imaging they agreed in 4 out of 5 cases, suggesting that 
future studies should explore the possibility that precise imaging may increase inter-rater 
reliability. Numbers are too few, however, to make meaningful conclusions about imaging 
modality in this article. In addition, missing data, especially for the chronic cases, may have 
caused an inability to determine a precise classification. Finally, these cases were selected 
from a cohort of patients identified in North America with exclusion criteria that included 
acute traumatic brain injury; meningitis or encephalitis; and status epilepticus.12 Therefore, 
generalizability to cases from international and less circumscribed populations needs to be 
explored.
Conclusions
Although the CASCADE criteria is a reliable and standardized system currently available 
for classification of childhood AIS, future efforts are needed to improve classification. These 
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efforts should focus on FCA, aortic/cervical arteriopathy, and small vessel arteriopathy 
primary categories, as well as on more precise definitions for hematologic and infectious 
disease secondary subtypes. One possible next step could be combining many of the 
techniques for classifying arteriopathies from the VIPS study (Vascular Effects of Infection 
in Pediatric Stroke),19 within an all-inclusive classification system such as the CASCADE 
criteria. This approach could lead to an improved system available for general use. 
Improvements in vascular imaging, such as imaging of the arterial wall itself, are also 
needed to better differentiate arteriopathies with distinct pathophysiologies. In addition, the 
use of computer-assisted classification and evidence-based criteria as they become available, 
will also likely enhance the reliability of the CASCADE criteria as has occurred in adult 
stroke.20,21 Finally, the challenge of uniformly agreeing on classification of focal 
intracranial arteriopathic remains—even among experts in the field—suggesting that 
continued efforts to refine classification tools are urgently needed in this field.
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Figure. 
Case assignment and rater classification flow chart. AIS indicates arterial ischemic stroke; 
CASCADE, Childhood AIS Standardized Classification and Diagnostic Evaluation.
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Table 1
CASCADE Criteria Primary Subtypes
Basic 7-Subtype CASCADE Criteria (Only 
One Selected) Expanded 19-Subtype CASCADE Criteria (Only One Selected)
□ SVA SVA
□ Definitive
□ Radiographic confirmation
□ Biopsy confirmation
□ Probable
□ Unilateral FCA FCA
□ Anterior circulation with collaterals
□ Anterior circulation without collaterals
□ Posterior circulation
□ Other
□ Bilateral cerebral arteriopathy of childhood Bilateral cerebral arteriopathy of childhood
□ With collaterals
□ Without collaterals
□ Other
□ Aortic/cervical arteriopathy Aortic/cervical arteriopathy
□ Dissection
□ Takayasu arteritis
□ Other
□ Cardioembolic Cardioembolic
□ Definite
□ Probable
□ Other Other
□ Undetermined cause
□ Other
□ Multifactorial Multifactorial
□ Multifactorial
CASCADE criteria secondary subtypes
Secondary subtypes (select as many as apply) Examples
□ Genetic: vasculopathy PHACES syndrome, Williams syndrome, trisomy 21, neurofibromatosis, Alagille 
syndrome, and sickle cell disease
□ Infectious Postvaricella arteriopathy, meningitis, and HIV vasculopathy
□ Hematologic/thrombotic Hemoglobinopathy, antiphospholipid antibody syndrome, inherited coagulation regulatory 
protein deficiency (protein S, protein C, antithrombin III), factor V Leiden or prothrombin 
mutation, elevated homocysteine, protein-losing states (enteropathy, hepatopathy, and 
nephropathy), and anemia
□ Inflammatory Idiopathic (primary central nervous system vasculitis), systemic inflammatory, or 
autoimmune disease (eg, lupus)
□ Genetic: metabolic Mitochondrial cytopathy
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Basic 7-Subtype CASCADE Criteria (Only 
One Selected) Expanded 19-Subtype CASCADE Criteria (Only One Selected)
□ Drug/toxin exposure Intravenous immunoglobulin, l-asparaginase, drugs of abuse, and postcranial irradiation
□ Vasospasm Reversible vasospastic syndromes
Definitions provided in Bernard et al.11 AIS indicates arterial ischemic stroke; CASCADE, Childhood AIS Standardized Classification and 
Diagnostic Evaluation; FCA, focal cerebral arteriopathy; PHACES, posterior fossa brain malformations, hemangiomas of the face, arterial 
abnormalities, cardiac anomalies, eye anomalies, sternal cleft/supraumbilical raphe; and SVA, small vessel arteriopathy.
Stroke. Author manuscript; available in PMC 2018 January 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Bernard et al. Page 12
Ta
bl
e 
2
Pa
irw
ise
 A
gr
ee
m
en
t B
et
w
ee
n 
Ra
te
rs
 b
y 
Ba
sic
 7
-S
ub
ty
pe
 C
A
SC
A
D
E 
Cr
ite
ria
Su
bt
yp
e
Ti
m
ef
ra
m
e
SV
A
FC
A
Bi
la
te
ra
l C
er
eb
ra
l 
A
rt
er
io
pa
th
y 
of
 C
hi
ld
ho
od
A
or
tic
/C
er
v
ic
al
 A
rt
er
io
pa
th
y
C
ar
di
oe
m
bo
lic
O
th
er
M
ul
tif
ac
to
ri
al
To
ta
l
SV
A
A
cu
te
0*
0
0
0
0
0
1
1
Ch
ro
ni
c
0*
0
0
0
0
0
1
1
FC
A
A
cu
te
0
7*
0
1
0
1
1
10
Ch
ro
ni
c
0
7*
0
0
0
1
1
9
B
ila
te
ra
l c
er
eb
ra
l a
rte
rio
pa
th
y 
of
 c
hi
ld
ho
od
A
cu
te
0
0
5*
0
0
0
0
5
Ch
ro
ni
c
0
0
3*
0
1
0
1
5
A
or
tic
/c
er
vi
ca
l a
rte
rio
pa
th
y
A
cu
te
0
2
0
4*
0
0
1
7
Ch
ro
ni
c
0
3
0
3*
0
0
1
7
Ca
rd
io
em
bo
lic
A
cu
te
0
0
0
0
16
*
2
0
18
Ch
ro
ni
c
0
0
0
0
15
*
1
1
17
O
th
er
A
cu
te
1
6
1
3
1
8*
2
22
Ch
ro
ni
c
1
7
1
2
2
9*
1
23
M
ul
tif
ac
to
ria
l
A
cu
te
0
0
0
0
1
0
0*
1
Ch
ro
ni
c
0
0
0
0
0
0
0*
0
To
ta
l
A
cu
te
1
15
6
8
18
11
5
64
Ch
ro
ni
c
1
17
4
5
18
11
6
62
Ea
ch
 c
el
l r
ep
re
se
nt
s t
he
 n
um
be
r o
f t
im
es
 o
ne
 re
v
ie
w
er
 g
av
e 
th
e 
re
sp
on
se
 in
 th
e 
co
lu
m
n 
la
be
l w
hi
le
 th
e 
ot
he
r g
av
e 
th
e 
re
sp
on
se
 in
 th
e 
ro
w
 la
be
l. 
A
IS
 in
di
ca
te
s a
rte
ria
l i
sc
he
m
ic
 st
ro
ke
; C
A
SC
A
D
E,
 C
hi
ld
ho
od
 
A
IS
 S
ta
nd
ar
di
ze
d 
Cl
as
sif
ic
at
io
n 
an
d 
D
ia
gn
os
tic
 E
va
lu
at
io
n;
 F
CA
, f
oc
al
 c
er
eb
ra
l a
rte
rio
pa
th
y;
 a
nd
 S
VA
, s
m
al
l v
es
se
l a
rte
rio
pa
th
y.
*
En
tri
es
 re
pr
es
en
t a
gr
ee
m
en
t.
Stroke. Author manuscript; available in PMC 2018 January 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Bernard et al. Page 13
Table 3
Inter-Rater Reliability of CASCADE Criteria by Primary Stroke Subtype
Subtype Acute Inter-Rater Reliability (κ) Chronic Inter-Rater Reliability (κ)
SVA of childhood −0.01 (95% CI=−0.04 to 0.01) na* (95% CI=na)
Unilateral FCA of childhood 0.49 (95% CI=0.23 to 0.76) 0.47 (95% CI=0.22 to 0.72)
Bilateral cerebral arteriopathy of childhood 0.90 (95% CI=0.71 to 1.00) 0.64 (95% CI=0.27 to 1.00)
Aortic/cervical arteriopathy 0.36 (95% CI=0.01 to 0.71) 0.30 (95% CI=−0.08 to 0.69)
Cardioembolic 0.84 (95% CI=0.70 to 0.99) 0.80 (95% CI=0.64 to 0.97)
Other 0.33 (95% CI=0.09 to 0.56) 0.38 (95% CI=0.16 to 0.61)
Multifactorial −0.04 (95% CI=−0.09 to 0.00) 0.45 (95% CI=0.09 to 0.81)
Combined 0.53 (95% CI=0.39 to 0.67) 0.49 (95% CI=0.35 to 0.64)
AIS indicates arterial ischemic stroke; CASCADE, Childhood AIS Standardized Classification and Diagnostic Evaluation; CI, confidence interval; 
FCA, focal cerebral arteriopathy; na, not applicable; and SVA, small vessel arteriopathy.
*All rated negative.
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Table 4
Inter-Rater Reliability of CASCADE Criteria by Secondary Stroke Subtype
Subtype Agreement Subtype Present Agreement Subtype Absent Disagreement Inter-Rater Reliability (κ)
Genetic: vasculopathy 7/64 (10.9%) 54/64 (84.4%) 3/64 (4.7%) 0.80 (95% CI=0.56 to 1.00)
Infectious 1/64 (1.6%) 50/64 (78.1%) 13/64 (21.5%) 0.03 (95% CI=−0.22 to 0.28)
Hematologic 6/64 (9.4%) 37/64 (57.8%) 21/64 (32.8%) 0.16 (95% CI=0.08 to 0.41)
Inflammatory 2/64 (3.1%) 59/64 (92.2%) 3/64 (4.7%) 0.55 (95% CI=0.09 to 1.00)
Genetic: metabolic 0/64 (0.0%) 63/64 (98.4%) 1/64 (1.6%) na*
Toxin 1/64 (1.6%) 60/64 (93.8%) 3/64 (4.7%) 0.38 (95% CI=0.18 to 0.93)
Vasospasm 0/64 (0.0%) 62/64 (96.9%) 2/64 (3.1%) na*
AIS indicates arterial ischemic stroke; CASCADE, Childhood AIS Standardized Classification and Diagnostic Evaluation; CI, confidence interval; 
and na, not applicable.
*All rated negative.
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